(R)-(+)-Aminoglutethimide – (55511-44-9)

aminoglutethimide, 125-84-8, dl-Aminoglutethimide, Cytadren, Orimeten, p-Aminoglutethimide, Elipten, 3-(4-aminophenyl)-3-ethylpiperidine-2, 6-dione, Aminoglutetimida, 2, 6-Piperidinedione, 3-(4-aminophenyl)-3-ethyl-, 3-(4-Aminophenyl)-3-ethyl-2, 6-piperidinedione, Aminoglutethimidum, 2-(p-Aminophenyl)-2-ethylglutarimide, Ba-16038, Aminoglutetimide, 3-Ethyl-3-(p-aminophenyl)-2, 6-dioxopiperidine, Ba 16038, CCRIS 7562, Aminoglutethimidum [INN-Latin], Aminoglutetimida [INN-Spanish], C 16038-BA, NSC-330915, Glutethimide, para-amino, Glutarimide, 2-(p-aminophenyl)-2-ethyl-, EINECS 204-756-4, MFCD00010122, 3-(4-Aminophenyl)-3-ethyl-2, 6-piperidindion, UNII-0O54ZQ14I9, BRN 0210656, AG-1, CHEBI:2654, 3-(4-aminophenyl)-3-ethyl-piperidine-2, 6-dione, DTXSID8022589, HSDB 7494, 0O54ZQ14I9, alpha-(p-Aminophenyl)-alpha-ethylglutarimide, CHEMBL488, DTXCID202589, Aminoglutethimide [USP:INN:BAN], NSC330915, NSC 330915, NSC 755868, (+/-)-p-AMINOGLUTETHIMIDE, .alpha.-(p-Aminophenyl)-.alpha.-ethylglutarimide, (RS)-2-(4-Amino-phenyl)-2-ethyl-glutarimide (RS)-3-(4-Amino-phenyl)-3-ethyl-2, 6-dioxo-piperidine, Aminoglutethimidum (INN-Latin), Aminoglutetimida (INN-Spanish), AMINOGLUTETHIMIDE (MART.), AMINOGLUTETHIMIDE [MART.], Aminoglutethimide (USP:INN:BAN), AMINOGLUTETHIMIDE (EP IMPURITY), AMINOGLUTETHIMIDE [EP IMPURITY], AMINOGLUTETHIMIDE (EP MONOGRAPH), AMINOGLUTETHIMIDE (USP IMPURITY), AMINOGLUTETHIMIDE [EP MONOGRAPH], AMINOGLUTETHIMIDE [USP IMPURITY], Cytadren (TN), SMR000326785, aminoglutethimide (AG), SR-01000075596, Aminoblastin, Mamomit, Orimenten, Orimetene, Rodazol, Aminoglutethimide (USP/INN), Aminoglutethimid, 3-(p-Aminophenyl)-3-ethylpiperidine-2, 6-dione, NCGC00016379-01, CAS-125-84-8, Prestwick_243, Spectrum_000040, (y)-p-Aminoglutethimide, Aminoglutethimide AG, 4, (?)-p-Aminoglutethimide, Prestwick0_000244, Prestwick1_000244, Prestwick2_000244, Prestwick3_000244, Spectrum2_000093, Spectrum3_000296, Spectrum4_000144, Spectrum5_000802, A 9657, SCHEMBL4306, Aminoglutethimide (Cytadren), Lopac0_000124, BSPBio_000028, BSPBio_001832, KBioGR_000588, KBioSS_000400, (A+/-)-p-Aminoglutethimide, MLS000859924, MLS001213216, AMINOGLUTETHIMIDE [MI], DivK1c_000884, SPECTRUM1500115, SPBio_000046, SPBio_002247, AMINOGLUTETHIMIDE [INN], BDBM9460, BPBio1_000032, GTPL7054, AMINOGLUTETHIMIDE [HSDB], AMINOGLUTETHIMIDE [VANDF], HMS502M06, KBio1_000884, KBio2_000400, KBio2_002968, KBio2_005536, KBio3_001332, NINDS_000884, AMINOGLUTETHIMIDE [WHO-DD], HMS1568B10, HMS1920C09, HMS2090I05, HMS2091I09, HMS2095B10, HMS2231M19, HMS3259H10, HMS3260I10, HMS3372M07, HMS3655O17, HMS3712B10, Pharmakon1600-01500115, BCP28501, HY-B0237, 2, 3-(4-aminophenyl)-3-ethyl-, Tox21_110406, Tox21_303497, Tox21_500124, BBL010961, CCG-38911, MFCD03094024, MFCD03094025, NSC755868, STK802074, Aminoglutethimide – Bio-X trade mark, AKOS004120070, AKOS022060651, Tox21_110406_1, AMINOGLUTETHIMIDE [ORANGE BOOK], DB00357, FA17754, LP00124, NC00714, NSC-755868, PB48252, SDCCGSBI-0050112.P005, IDI1_000884, SMP1_000017, NCGC00015110-02, NCGC00015110-03, NCGC00015110-04, NCGC00015110-05, NCGC00015110-06, NCGC00015110-07, NCGC00015110-09, NCGC00015110-12, NCGC00015110-21, NCGC00093615-01, NCGC00093615-02, NCGC00093615-03, NCGC00093615-04, NCGC00093615-05, NCGC00257263-01, NCGC00260809-01, AC-12456, AS-13282, BA164155, NCI60_002900, SY294287, SY344150, SBI-0050112.P004, DB-021640, DB-072002, DB-072275, A1947, AB00051935, alpha-(4-Aminophenyl)-alpha-ethylglutarimide, EU-0100124, NS00010649, S1672, SW196550-3, ( inverted question mark)-p-Aminoglutethimide, EN300-53368, VU0243029-3, C07617, D00574, D88489, AB00051935-09, AB00051935-11, AB00051935_12, AB00051935_13, Q241150, SR-01000075596-1, SR-01000075596-4, SR-01000075596-6, (R)-3-(4-Aminophenyl)-3-ethylpiperidine-2, 6-dione, (S)-3-(4-aminophenyl)-3-ethylpiperidine-2, 6-dione, BRD-A25234499-001-05-0, BRD-A25234499-001-09-2, BRD-A25234499-001-17-5, BRD-A25234499-001-18-3, BRD-A25234499-001-19-1, Z800191876, Aminoglutethimide, European Pharmacopoeia (EP) Reference Standard, Aminoglutethimide, United States Pharmacopeia (USP) Reference Standard, 204-756-4